NCT05845450 2026-03-12Pre-operative Targeted Treatments in Molecularly Selected Resectable Colorectal Cancer (UNICORN)Gruppo Oncologico del Nord-OvestPhase 2 Recruiting197 enrolled
NCT06855849 2025-03-04An Open-label, Single-arm, Multicenter Phase II Study to Evaluate the Efficacy of Amivantamab in Combination With FOLFIRI as a Second-line Treatment in Patients With RAS/BRAF Wild-type Advanced Colorectal Cancer Progressing on Prior Anti-EGFR Based Treatment.Yonsei UniversityPhase 2 Not yet recruiting85 enrolled